Risperidone/Rumenic acid

N/A

Report date: 2022/02/24 10:02:56

Base Information

Drug NameRisperidone/Rumenic acid
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonistsDopamine D2 receptor antagonists
TargetsSerotonin 2a (5-HT2a) receptorDopamine D2 receptor
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Risperidone
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesValiseek Overview
China Registration ClassN/A

Develop Information

Active CompaniesValiseek Overview
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A